School patents method using umbilical cord-blood cells

07/9/2010 | American City Business Journals

The University of South Florida's department of neurosurgery and brain repair has received a patent for a cell transplantation method that uses human umbilical cord-blood cells in combination with a compound called mannitol to treat neurodegenerative diseases. Saneron CCEL Therapeutics, a biotech research and development company, has licensed the technology.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
PacificSource
Boise, ID